Merck Archives -

To celebrate International Women’s Day, we speak to design engineer at Envair Technology Darina Shopova; general manager, UK

IWD: Spotlight on women in life sciences

https://pharmaphorum.com/views-and-analysis/international-womens-day-spotlight-on-women-life-sciences/

Oncology/ Podcast/ Video/ Views & Analysis/ Views and analysis

Merck on trends in oncology: the pharmaphorum podcast

Dominic Tyer Merck, patient outcomes 0 Comment

Episode 45 of the pharmaphorum podcast heard from Dr Stuart Hill, how he’s seen the oncology landscape change

Merck on trends in oncology: the pharmaphorum podcast

https://pharmaphorum.com/video/merck-on-trends-in-oncology/

R&D/ Views & Analysis/ Views and analysis

Pharma’s pipeline continues to provide drama as investors look beyond COVID in Q4

mike.hammerton@pharmaphorum.com Biogen, GSK, Merck, Q4 2021, quarterly results 0 Comment

While the pandemic has been the focus of R&D attention for much of 2020, that is slowly beginning

Pharma’s pipeline continues to provide drama as investors look beyond COVID in Q4

https://pharmaphorum.com/r-d/views-analysis-r-d/pharmas-pipeline-continues-to-provide-drama-as-investors-look-beyond-covid-in-q4/

Market Access/ Oncology/ R&D/ Views & Analysis/ Views & Analysis/ Views & Analysis/ Views and analysis

A history of the pharmaceutical industry

Rebecca A history of..., Aspirin, Bayer, Eli Lilly, GSK, History of the pharmaceutical industry, insulin, Merck, NHS, penicillin, Pfizer, Sandoz, Wyeth 0 Comment

Robin Walsh takes a look back at the origins of the industry in the 19th century and its ongoing evolution

A history of the pharmaceutical industry

https://pharmaphorum.com/r-d/a_history_of_the_pharmaceutical_industry/

Merck group communications head Thomas Moeller

News/ News/ Sales and Marketing

Merck makes communications leadership change

Darcy Jimenez comms, Merck 0 Comment

German pharmaceutical company Merck has appointed Thomas Möller as its new head of group communications. Most recently responsible

Merck makes communications leadership change

https://pharmaphorum.com/news/merck-communications-thomas-moller/

Market Access/ Sales and Marketing/ Views & Analysis/ Views & Analysis/ Views and analysis

MSD’s David Peacock on moving UK healthcare forward

mike.hammerton@pharmaphorum.com coronavirus, COVID-19, Merck, Merck & Co, MSD, NHS, UK, UK Leaders 0 Comment

David Peacock has worked across the world for MSD and other companies, and has now taken the helm

MSD’s David Peacock on moving UK healthcare forward

https://pharmaphorum.com/views-analysis-sales-marketing/msds-david-peacock-on-moving-uk-healthcare-forward/

Deep Dive/ Patients/ Views & Analysis/ Views and analysis

True pharma-patient co-creation

mike.hammerton@pharmaphorum.com co-creation, Deep Dive, Merck, MS patient group, Trishna Bharadia 0 Comment

A recent MS patient group forum hosted by Merck KGaA demonstrates the power of true co-creation with patients.

True pharma-patient co-creation

https://pharmaphorum.com/views-analysis-patients/true-pharma-patient-co-creation-merck-ms/

Keeping up the PACE at the Scottish Medicines Consortium

News

SMC approves medicines for breast cancer, skin cancer, schizophrenia

George Underwood Allergan, Eli Lilly, Keytruda, Lilly, Merck, Reagila, Scotland, SMC, Vernezio, Vernezios, Xonvea 0 Comment

The Scottish Medicines Consortium (SMC) has given approvals to Lilly’s breast cancer drug Verzenios, Merck’s Keytruda and Allergan’s

SMC approves medicines for breast cancer, skin cancer, schizophrenia

https://pharmaphorum.com/news/smc-approves-medicines-for-breast-cancer-skin-cancer-schizophrenia/

Market Access/ News/ News/ Top stories

AZ and MSD’s Lynparza gets EU nod for hard-to-treat breast cancer

George Underwood AstraZeneca, breast cancer, Lynparza, Merck, MSD 0 Comment

The European Commission has approved AstraZeneca and MSD’s Lynparza (olaparib) for the treatment of germline BRCA-mutated HER2-negative advanced

AZ and MSD’s Lynparza gets EU nod for hard-to-treat breast cancer

https://pharmaphorum.com/news/az-and-msds-lynparza-gets-eu-nod-for-hard-to-treat-breast-cancer/

Trending

Merck

Login